Abbott Laboratories financials at a glance

Year Year 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2022 2021 2023 2024
Rev. Revenue
$34.61B $31.90B $30.58B $27.39B $20.85B $20.41B $20.25B $19.66B $19.05B $21.41B $35.17B $30.76B $29.53B $25.91B $22.48B $22.34B $19.68B $43.65B $43.08B $40.11B $0.00M
GM % Gross Margin %
57.08% 58.53% 58.48% 58.05% 56.43% 57.22% 54.61% 53.36% 53.54% 53.42% 58.74% 57.06% 57.72% 56.29% 57.14% 53.14% 54.86% 56.31% 58.06% 55.18% 0.00%
OM Operating Margin
16.37% 14.91% 12.55% 10.73% 15.43% 14.52% 14.26% 11.14% 8.01% 7.82% 20.02% 21.19% 20.17% 18.08% 18.98% 20.75% 21.86% 20.24% 21.40% 16.15% 0.00%
EPS Earnings Per Share
$2.50 $2.53 $2.84 $3.32 $3.72 $4.17 $4.66 $5.07 $2.01 $1.98 $2.15 $2.20 $2.50 $2.88 $3.24 $3.65 $5.21 $5.34 $4.43 $0.00
Div. Dividends
$1.53 $1.32 $1.16 $1.08 $1.05 $0.98 $0.90 $0.72 $1.67 $1.92 $1.76 $1.60 $1.44 $1.30 $1.18 $1.10 $1.04 $1.92 $1.82 $2.01 $0.00
PR % Payout Ratio %
41.92% 40.74% 40.28% 43.20% 47.73% 45.58% 45.45% 35.82% 32.94% 41.20% 42.21% 43.01% 43.37% 45.77% 46.64% 44.00% 45.81% 35.96% 34.93% 45.37% 0
Sha. Shares
1713.4m 1768.46m 1756.33m 1740.6m 1472.31m 1491.72m 1505.79m 1546.19m 1580.67m 1557.8m 1545.82m 1546.74m 1551.58m 1545.27m 1534.86m 1551.23m 1557.39m 1743.57m 1714.97m 1736.06m 1736.06m
OCF Operating Cash Flow
$7.90B $6.14B $6.30B $5.57B $3.20B $2.97B $3.68B $3.32B $9.31B $8.97B $8.74B $7.28B $7.34B $5.18B $5.33B $5.17B $5.11B $9.58B $10.53B $0.00M $0.00M
FCF Free Cash Flow
$5.72B $4.50B $4.91B $4.44B $2.08B $1.86B $2.60B $2.18B $7.52B $7.48B $7.72B $6.19B $6.06B $3.53B $3.99B $3.97B $3.82B $7.80B $8.65B $8.08B $0.00M
FCFS Free Cash Flow Per Share
$3.23 $2.54 $2.79 $2.55 $1.41 $1.24 $1.71 $1.40 $4.77 $4.80 $4.99 $4.00 $3.92 $2.29 $2.61 $2.56 $2.45 $4.45 $4.87 $0.00 $0.00